Montrose Dialysis (DCI) is a medicare approved dialysis facility center in Montrose, Colorado and it has 10 dialysis stations. It is located in Montrose county at 846 South 5th Street, Montrose, CO, 81401. You can reach out to the office of Montrose Dialysis (DCI) at (970) 240-3302. This dialysis clinic is managed and/or owned by Dialysis Clinic, Inc.. Montrose Dialysis (DCI) has the following ownership type - Non-Profit. It was first certified by medicare in August, 1998. The medicare id for this facility is 062530 and it accepts patients under medicare ESRD program.
| Name | Montrose Dialysis (DCI) |
|---|---|
| Location | 846 South 5th Street, Montrose, Colorado |
| No. of Dialysis Stations | 10 |
| Medicare ID | 062530 |
| Managed By | Dialysis Clinic, Inc. |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 846 South 5th Street, Montrose, Colorado, 81401 | |
| (970) 240-3302 | |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
| NPI Number | 1225057466 |
| Doing Business As | Dialysis Clinic Inc. |
| Address | 945 S 4th St Montrose, Colorado, 81401 |
| Phone Number | (970) 240-3302 |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 17 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 336 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
| Adult patients getting regular peritoneal dialysis at the center | 3 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 24 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Montrose Dialysis (DCI) with elevated calcium levels.
| Patients with hypercalcemia | 41 |
| Hypercalcemia patient months | 387 |
| Patients with Serumphosphor | 44 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 5 |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 33 |
| Patient months included in arterial venous fistula and catheter summaries | 244 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 30 |
| Hospitalization Rate in facility | 98.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 256 |
| Hospitalization Rate: Lower Confidence Limit | 41 |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Montrose Dialysis (DCI) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 15.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36.9 |
| Readmission Rate: Lower Confidence Limit | 3.5 |
News Archive
A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.
NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.
A team of researchers report a significant genetic association linked to an aggressive form of melanoma in a study published today in the journal Genome Research.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.
› Verified 7 days ago